Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO2 pseudogene 29 (MTCO2P29) is a non-functional DNA segment in the human genome corresponding to the mitochondrial gene MT-CO2, which encodes the cytochrome c oxidase II subunit in mitochondria. Unlike the active MT-CO2 gene that contributes to mitochondrial electron transport and is associated with various mitochondrial diseases, MTCO2P29 is a pseudogene—meaning it does not produce a functional protein and lacks known therapeutic or biological significance. MTCO2P29 is located on chromosome 3 (chr3:120722458-120722646, GRCh38). No drugs, disease roles, or biomarkers are linked to this pseudogene in current biomedical databases. This entity is not a therapeutic target or active molecular entity; it is a pseudogene with no known function, drug interactions, or disease association. If you are seeking information about a drug target, you may wish to consult the canonical MT-CO2 gene (“Mitochondrially encoded cytochrome c oxidase II”), which is the functional counterpart and has relevance for mitochondrial disease and metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome c oxidase II pseudogene 29 (MTCO2P29).